Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
NEW YORK, April 2, 2025 /PRNewswire/ — Medivis Inc., a pioneer in surgical intelligence, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Spine Navigation platform. This milestone marks a significant advancement in surgical technology, utilizing AR and AI to empower surgeons with holographic navigation across open and minimally invasive spine procedures. Alongside the FDA clearance, Medivis is announcing the commercial launch of Spine Navigation, making it available to hospitals and ambulatory surgical centers nationwide.
“Surgery is entering a new era of advanced computing that enhances precision, speed, and efficiency in the operating room. This is a pivotal moment in medicine, and we are thrilled to deliver a solution that will elevate patient care to new heights,” said Dr. Christopher Morley, President of Medivis.
“At Medivis, we envision a future where surgical navigation transcends boundaries by integrating imaging data with the operative field. With our recent FDA clearance for Spine Navigation, we are thrilled to equip surgeons with breakthrough technology to visually transform spine surgery and empower them with intuitive image guidance,” added Dr. Osamah Choudhry, CEO of Medivis.
Medivis’ Spine Navigation platform is applicable across neurosurgery and orthopedic surgery. Its key strengths include:
Spine Navigation is the latest addition to the company’s portfolio of AI-powered surgical solutions, which are designed to transform the operating room and enhance surgical precision across a range of specialties.
About Medivis
Medivis is a leading surgical intelligence company dedicated to pioneering the future of surgical navigation with artificial intelligence and augmented reality. To learn more, visit www.medivis.com.
Contact: brooke@medivis.com
SOURCE Medivis
BUENOS AIRES, ARGENTINA, MARCH 31, 2026 ― When the Teatro Colón opens its doors to…
Creative Technology Group, Inc. (CT), the NEP Live Events group, has invested in multiple Analog…
AiGS will leverage n8n's platform to deliver future-ready automation solutions that streamline operations and unlock…
First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinical efficacy and a favorable GLP safety…
PHOENIX, AZ / ACCESS Newswire / March 31, 2026 / 1606 Corp. (OTCID:CBDW) ("1606" or…
Company Invites Investors to Submit Questions to be Answered on the Webcasted Earnings Call TORONTO,…